HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 49578,
"recordsTotal": 49578,
"next": null,
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=sponsor__name&start=49200",
"results": [
{
"registry_id": "NCT04699591",
"publication_url": "https://clinicaltrials.gov/study/NCT04699591",
"title": "Compassionate Use of Domperidone for Refractory Gastroparesis",
"has_exemption": false,
"start_date": "2013-04-30",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jose Cocjin",
"sponsor_slug": "jose-cocjin",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02469662",
"publication_url": "https://clinicaltrials.gov/study/NCT02469662",
"title": "Retrospective and Prospective Clinical Outcomes Study of the Zimmer® Nexel™ Total Elbow",
"has_exemption": false,
"start_date": "2015-06-30",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04042025",
"publication_url": "https://clinicaltrials.gov/study/NCT04042025",
"title": "A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101",
"has_exemption": false,
"start_date": "2020-02-10",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Gene Therapies",
"sponsor_slug": "novartis-gene-therapies",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06697301",
"publication_url": "https://clinicaltrials.gov/study/NCT06697301",
"title": "A Multicenter, Randomized, Double-Blind, Active Comparator-Controlled, Adaptive Phase 2/3 Study to Evaluate the Safety and Efficacy of EIK1001 and Pembrolizumab Versus Placebo and Pembrolizumab as First-Line Therapy in Participants With Advanced Melanoma (TeLuRide-006)",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eikon Therapeutics",
"sponsor_slug": "eikon-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282834",
"publication_url": "https://clinicaltrials.gov/study/NCT07282834",
"title": "Randomized Phase II Trial of Heated Vs. Pressurized/Aerosolized Chemotherapy (HIPEC vs. PIPAC) for Peritoneal Carcinomatosis",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Patrick Wagner, MD, FACS",
"sponsor_slug": "patrick-wagner-md-facs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07186634",
"publication_url": "https://clinicaltrials.gov/study/NCT07186634",
"title": "Domain-Specific Appendix: OXYGEN",
"has_exemption": false,
"start_date": "2026-04-06",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Monash University",
"sponsor_slug": "monash-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07365319",
"publication_url": "https://clinicaltrials.gov/study/NCT07365319",
"title": "A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer (TeLuRide-008).",
"has_exemption": false,
"start_date": "2026-06-15",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eikon Therapeutics",
"sponsor_slug": "eikon-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07447076",
"publication_url": "https://clinicaltrials.gov/study/NCT07447076",
"title": "A Platform Study of Novel Therapies for Children, Adolescents and Young Adults With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)",
"has_exemption": false,
"start_date": "2026-06-17",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sabine Mueller, MD, PhD",
"sponsor_slug": "sabine-mueller-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07240649",
"publication_url": "https://clinicaltrials.gov/study/NCT07240649",
"title": "Emerging Indications for Hyperbaric Oxygen Treatment",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jay C. Buckey Jr.",
"sponsor_slug": "jay-c-buckey-jr",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04074135",
"publication_url": "https://clinicaltrials.gov/study/NCT04074135",
"title": "Evaluation of the Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2020-06-02",
"completion_date": "2036-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07308886",
"publication_url": "https://clinicaltrials.gov/study/NCT07308886",
"title": "Phase II Study of Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-response (REGIMEN-KS HIV)",
"has_exemption": false,
"start_date": "2026-04-08",
"completion_date": "2036-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02445222",
"publication_url": "https://clinicaltrials.gov/study/NCT02445222",
"title": "Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-Cell Therapy",
"has_exemption": false,
"start_date": "2015-11-02",
"completion_date": "2036-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06892522",
"publication_url": "https://clinicaltrials.gov/study/NCT06892522",
"title": "A Phase 1/2, Open-Label, Platform Study to Evaluate Safety and Efficacy of Etentamig Monotherapy or Etentamig Combinations in Subjects With Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2036-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07677839",
"publication_url": "https://clinicaltrials.gov/study/NCT07677839",
"title": "Redefining the Normal: Ultra-High Frequency Ultrasound Characterization of Lymphatic Anatomy in Patients With Breast Cancer",
"has_exemption": false,
"start_date": "2026-06-17",
"completion_date": "2036-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05767047",
"publication_url": "https://clinicaltrials.gov/study/NCT05767047",
"title": "A Phase 3, Multicenter, Open-label, Long-term Extension Study of Apremilast in Children 2 Years of Age or Older With Oral Ulcers Associated With Behçet's Disease or 5 Years of Age or Older With Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2036-03-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07577414",
"publication_url": "https://clinicaltrials.gov/study/NCT07577414",
"title": "Infant Survival and Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia, A Phase III Trial",
"has_exemption": false,
"start_date": "2026-06-17",
"completion_date": "2036-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dr Erin Perrone",
"sponsor_slug": "dr-erin-perrone",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02201992",
"publication_url": "https://clinicaltrials.gov/study/NCT02201992",
"title": "A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein",
"has_exemption": false,
"start_date": "2015-03-23",
"completion_date": "2036-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03955445",
"publication_url": "https://clinicaltrials.gov/study/NCT03955445",
"title": "An Open-label, Non-randomized Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Iptacopan (LNP023) in C3 Glomerulopathy or Idiopathic Immune-complex-membranoproliferative Glomerulonephritis",
"has_exemption": false,
"start_date": "2019-10-03",
"completion_date": "2036-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06918002",
"publication_url": "https://clinicaltrials.gov/study/NCT06918002",
"title": "A Phase 3, Open-label, Controlled, Randomized Study of Newly Diagnosed Multiple Myeloma Treatment, Designed to Evaluate the Efficacy and Safety of the Elranatamab-lenalidomide Combination as a Replacement for Chemotherapy Followed by Autologous Stem Cell Transplant in the Consolidation Phase, and to Compare Elranatamab With Standard of Care in the Maintenance Phase",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2036-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Intergroupe Francophone du Myelome",
"sponsor_slug": "intergroupe-francophone-du-myelome",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07250477",
"publication_url": "https://clinicaltrials.gov/study/NCT07250477",
"title": "Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2036-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07393373",
"publication_url": "https://clinicaltrials.gov/study/NCT07393373",
"title": "Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Hypochondroplasia: ACCEL OLE",
"has_exemption": false,
"start_date": "2026-04-23",
"completion_date": "2036-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "QED Therapeutics, a BridgeBio company",
"sponsor_slug": "qed-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07659379",
"publication_url": "https://clinicaltrials.gov/study/NCT07659379",
"title": "Extension Trial to Study the Long-term Safety and Efficacy in Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in Gotistobart Trials",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2036-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OncoC4, Inc.",
"sponsor_slug": "oncoc4-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07671768",
"publication_url": "https://clinicaltrials.gov/study/NCT07671768",
"title": "ONE SHOT: Single-Fraction Adaptive MR-Guided Radiation Therapy for Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2036-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05441813",
"publication_url": "https://clinicaltrials.gov/study/NCT05441813",
"title": "A Randomized, Open-label Study of Coconut Oil Mouth Rinse for Prophylaxis of Severe Oral Mucositis in Pediatric Patients Receiving Myeloablative Conditioning Regimens",
"has_exemption": false,
"start_date": "2023-02-15",
"completion_date": "2036-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07708961",
"publication_url": "https://clinicaltrials.gov/study/NCT07708961",
"title": "Randomized Phase II Trial to Evaluate the Efficacy of WSD0922-FU When Combined With Adjuvant Temozolomide in Patients With EGFR Mutant Glioblastoma",
"has_exemption": false,
"start_date": "2026-08-16",
"completion_date": "2036-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06342999",
"publication_url": "https://clinicaltrials.gov/study/NCT06342999",
"title": "Evaluation of Outcomes of Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2036-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mauro H. Schenone",
"sponsor_slug": "mauro-h-schenone",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07654257",
"publication_url": "https://clinicaltrials.gov/study/NCT07654257",
"title": "Single FrAction Interstitial BreaSt BracHytherApy (SASHA)",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2036-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07667400",
"publication_url": "https://clinicaltrials.gov/study/NCT07667400",
"title": "Phase I/II Trial of Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer",
"has_exemption": false,
"start_date": "2026-07-22",
"completion_date": "2036-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07420959",
"publication_url": "https://clinicaltrials.gov/study/NCT07420959",
"title": "Phase 1/2 Trial of ABBV-383 for Patients With Relapsed Refractory Waldenström Macroglobulinemia",
"has_exemption": false,
"start_date": "2026-10-25",
"completion_date": "2036-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03435796",
"publication_url": "https://clinicaltrials.gov/study/NCT03435796",
"title": "Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells",
"has_exemption": false,
"start_date": "2018-07-19",
"completion_date": "2036-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072482",
"publication_url": "https://clinicaltrials.gov/study/NCT06072482",
"title": "A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Participants With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis",
"has_exemption": false,
"start_date": "2024-02-07",
"completion_date": "2036-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05669846",
"publication_url": "https://clinicaltrials.gov/study/NCT05669846",
"title": "Phase II Feasibility Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2036-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06974279",
"publication_url": "https://clinicaltrials.gov/study/NCT06974279",
"title": "Precision Neuromodulation in Post-Stroke Aphasia Using TMS",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2036-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06932562",
"publication_url": "https://clinicaltrials.gov/study/NCT06932562",
"title": "A Randomized, Open-Label, Controlled Phase 3 Study of Comparing Daratumumab, Lenalidomide and Dexamethasone Induction Followed by Linvoseltamab Versus Continued Daratumumab, Lenalidomide, and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients",
"has_exemption": false,
"start_date": "2025-12-23",
"completion_date": "2036-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "European Myeloma Network B.V.",
"sponsor_slug": "european-myeloma-network-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05548972",
"publication_url": "https://clinicaltrials.gov/study/NCT05548972",
"title": "Global, Multicenter and Prospective Post-Market Clinical Follow-Up Study of the G7® Dual Mobility Acetabular System With Vivacit-E® or Longevity® Poly Bearing & Instrumentation",
"has_exemption": false,
"start_date": "2023-03-20",
"completion_date": "2037-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06938399",
"publication_url": "https://clinicaltrials.gov/study/NCT06938399",
"title": "Motiva Implants® Post-Approval Study (PAS) Protocol for Motiva SmoothSilk® Round Ergonomix® ('Ergonomix®') and SmoothSilk® Round ('Round') Breast Implants in Subjects Who Are Undergoing Primary Breast Augmentation, Revision Augmentation and Other Aesthetic Procedures",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2037-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Motiva USA LLC",
"sponsor_slug": "motiva-usa-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03935893",
"publication_url": "https://clinicaltrials.gov/study/NCT03935893",
"title": "A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Advanced Solid Cancers",
"has_exemption": false,
"start_date": "2019-12-03",
"completion_date": "2037-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Udai Kammula",
"sponsor_slug": "udai-kammula",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05201781",
"publication_url": "https://clinicaltrials.gov/study/NCT05201781",
"title": "Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel",
"has_exemption": false,
"start_date": "2022-03-09",
"completion_date": "2037-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986382",
"publication_url": "https://clinicaltrials.gov/study/NCT06986382",
"title": "Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset (EO), Medically Refractory (MR) Crohn Disease (CD)",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2037-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05281809",
"publication_url": "https://clinicaltrials.gov/study/NCT05281809",
"title": "A Feasibility Study Following a Phase 2a Design to Demonstrate Successful Local Manufacture of Chimeric Antigen Receptor (CAR) T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2022-04-19",
"completion_date": "2037-08-05",
"has_results": false,
"results_due": false,
"sponsor_name": "John Lister",
"sponsor_slug": "john-lister",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214532",
"publication_url": "https://clinicaltrials.gov/study/NCT07214532",
"title": "SIgnatera-Guided Initiation of Adjuvant CDK4/6 Inhibitor in Intermediate Risk HR+ HER2- Breast Cancer",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2037-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Natera, Inc.",
"sponsor_slug": "natera-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06191744",
"publication_url": "https://clinicaltrials.gov/study/NCT06191744",
"title": "A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) Compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma (EPCORE™FL-2)",
"has_exemption": false,
"start_date": "2024-02-05",
"completion_date": "2037-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06661720",
"publication_url": "https://clinicaltrials.gov/study/NCT06661720",
"title": "Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma - STRIKE",
"has_exemption": false,
"start_date": "2025-03-14",
"completion_date": "2037-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07116473",
"publication_url": "https://clinicaltrials.gov/study/NCT07116473",
"title": "A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients With Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy (ACT-EARLY OLE)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2037-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eidos Therapeutics, a BridgeBio company",
"sponsor_slug": "eidos-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07637513",
"publication_url": "https://clinicaltrials.gov/study/NCT07637513",
"title": "Phase III Trial of Consolidation Tarlatamab + Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer (LS-SCLC)",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2037-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PrECOG, LLC.",
"sponsor_slug": "precog-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06651281",
"publication_url": "https://clinicaltrials.gov/study/NCT06651281",
"title": "A Phase 3 Extension Study to Evaluate the Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis",
"has_exemption": false,
"start_date": "2024-11-25",
"completion_date": "2037-12-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05587244",
"publication_url": "https://clinicaltrials.gov/study/NCT05587244",
"title": "Multicenter, Prospective Post-Market Clinical Follow-Up Study of the G7® Freedom Constrained Vivacit-E® Liners",
"has_exemption": false,
"start_date": "2023-05-08",
"completion_date": "2037-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01770418",
"publication_url": "https://clinicaltrials.gov/study/NCT01770418",
"title": "A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2013-03-31",
"completion_date": "2038-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04192591",
"publication_url": "https://clinicaltrials.gov/study/NCT04192591",
"title": "A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)",
"has_exemption": false,
"start_date": "2020-01-30",
"completion_date": "2038-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03989947",
"publication_url": "https://clinicaltrials.gov/study/NCT03989947",
"title": "A Phase 2 Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia",
"has_exemption": false,
"start_date": "2019-06-12",
"completion_date": "2038-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03538899",
"publication_url": "https://clinicaltrials.gov/study/NCT03538899",
"title": "Phase I/II Safety and Efficacy Study of Gene Transfer for Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID) in Newly Diagnosed Patients Using Self-Inactivating Lentiviral Vector (AProArt) to Transduce Autologous CD34 Hematopoietic Cells",
"has_exemption": false,
"start_date": "2018-05-31",
"completion_date": "2038-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05976763",
"publication_url": "https://clinicaltrials.gov/study/NCT05976763",
"title": "A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy With Zanubrutinib as Upfront Treatment in Older Patients With Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2023-10-20",
"completion_date": "2038-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00912041",
"publication_url": "https://clinicaltrials.gov/study/NCT00912041",
"title": "BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia",
"has_exemption": false,
"start_date": "2009-05-31",
"completion_date": "2038-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Leigh R. Hochberg, MD, PhD.",
"sponsor_slug": "leigh-r-hochberg-md-phd",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04081701",
"publication_url": "https://clinicaltrials.gov/study/NCT04081701",
"title": "68Ga(Gallium)-DOTATATE Positron Emission Tomography (PET)/MRI in the Diagnosis and Management of Somatostatin Receptor Positive Central Nervous System CNS Tumors.",
"has_exemption": false,
"start_date": "2019-09-04",
"completion_date": "2038-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929807",
"publication_url": "https://clinicaltrials.gov/study/NCT05929807",
"title": "A Phase 2, Multicenter, Long-Term, Open Label Extension Trial Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children and Adolescents With Achondroplasia",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2039-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ascendis Pharma Growth Disorders A/S",
"sponsor_slug": "ascendis-pharma-growth-disorders-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226388",
"publication_url": "https://clinicaltrials.gov/study/NCT07226388",
"title": "Hemiarthroplasty Versus Total Shoulder Arthroplasty for the Treatment of Glenohumeral Osteoarthritis: The Impact of Modern Implant Options",
"has_exemption": false,
"start_date": "2026-02-03",
"completion_date": "2039-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06582745",
"publication_url": "https://clinicaltrials.gov/study/NCT06582745",
"title": "Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib",
"has_exemption": false,
"start_date": "2024-06-24",
"completion_date": "2039-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cook Children's Health Care System",
"sponsor_slug": "cook-childrens-health-care-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06498635",
"publication_url": "https://clinicaltrials.gov/study/NCT06498635",
"title": "Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants With Early StaGe Non Small Cell Lung Cancer to Optimize ImmunotHerapy in The AdjuvanT Setting (INSIGHT)",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2039-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06652633",
"publication_url": "https://clinicaltrials.gov/study/NCT06652633",
"title": "A Long-term Follow-up Study for Patients Treated With Galapagos CAR T-cell Therapies",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2039-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lakefront Biotherapeutics NV",
"sponsor_slug": "lakefront-biotherapeutics-nv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06598371",
"publication_url": "https://clinicaltrials.gov/study/NCT06598371",
"title": "A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2039-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04208529",
"publication_url": "https://clinicaltrials.gov/study/NCT04208529",
"title": "A Long-term Follow-up Study of Subjects With β-thalassemia or Sickle Cell Disease Treated With Autologous CRISPR-Cas9 Modified Hematopoietic Stem Cells (CTX001)",
"has_exemption": false,
"start_date": "2021-01-20",
"completion_date": "2039-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07431827",
"publication_url": "https://clinicaltrials.gov/study/NCT07431827",
"title": "A Phase 3, Randomized, Double-blind Study of Adjuvant MK-1084 Plus Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus Adjuvant Placebo Plus MK-3475A in Participants With Completely Resected Stage IIA-IIIB (N2), KRAS G12C-mutant Non-small Cell Lung Cancer Following Receipt of Either Neoadjuvant Pembrolizumab Plus Chemotherapy or Adjuvant Chemotherapy (KANDLELIT-013)",
"has_exemption": false,
"start_date": "2026-03-18",
"completion_date": "2039-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02598349",
"publication_url": "https://clinicaltrials.gov/study/NCT02598349",
"title": "A Phase II Trial of Escalated Dose Proton Radiotherapy With Elective Nodal Irradiation and Concomitant Chemotherapy for Patients With Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2016-04-30",
"completion_date": "2039-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06617286",
"publication_url": "https://clinicaltrials.gov/study/NCT06617286",
"title": "MAC-CAR: A Phase 1B/II Trial of Myeloablative Conditioning and Autologous Stem Cell Transplantation Followed by Autologous CD30+ CAR T Cells in Children, Adolescents and Young Adults With Poor-Risk Classical Hodgkin Lymphoma (cHL)",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2039-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "New York Medical College",
"sponsor_slug": "new-york-medical-college",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03007589",
"publication_url": "https://clinicaltrials.gov/study/NCT03007589",
"title": "Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics",
"has_exemption": false,
"start_date": "2014-04-30",
"completion_date": "2040-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Protection Foundation",
"sponsor_slug": "sun-protection-foundation",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05568719",
"publication_url": "https://clinicaltrials.gov/study/NCT05568719",
"title": "A PHASE 3, NON-INVESTIGATIONAL PRODUCT, MULTI COUNTRY COHORT STUDY TO DESCRIBE THE LONG-TERM SAFETY AND EFFECTIVENESS OF A PRIOR SINGLE-DOSE TREATMENT WITH INVESTIGATIVE GIROCTOCOGENE FITELPARVOVEC OR FIDANACOGENE ELAPARVOVEC IN PARTICIPANTS WITH HEMOPHILIA A OR HEMOPHILIA B, RESPECTIVELY",
"has_exemption": false,
"start_date": "2022-12-28",
"completion_date": "2040-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05849480",
"publication_url": "https://clinicaltrials.gov/study/NCT05849480",
"title": "A Phase I/II Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)",
"has_exemption": false,
"start_date": "2024-05-08",
"completion_date": "2040-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05620771",
"publication_url": "https://clinicaltrials.gov/study/NCT05620771",
"title": "Phase II Study Therasphere® (Yttrium-90) in Combination With Systemic Therapy in Patients With High-risk Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2022-11-30",
"completion_date": "2040-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02689440",
"publication_url": "https://clinicaltrials.gov/study/NCT02689440",
"title": "Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib and Venetoclax: A Phase II Study",
"has_exemption": false,
"start_date": "2016-02-19",
"completion_date": "2040-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07073014",
"publication_url": "https://clinicaltrials.gov/study/NCT07073014",
"title": "A Phase 3, Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Vosoritide in Children With Hypochondroplasia",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2040-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02760849",
"publication_url": "https://clinicaltrials.gov/study/NCT02760849",
"title": "WISP (Women Choosing Surgical Prevention)",
"has_exemption": false,
"start_date": "2016-05-02",
"completion_date": "2041-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07095452",
"publication_url": "https://clinicaltrials.gov/study/NCT07095452",
"title": "Phase 2/3, Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Subjects With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant",
"has_exemption": false,
"start_date": "2026-01-08",
"completion_date": "2042-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05962346",
"publication_url": "https://clinicaltrials.gov/study/NCT05962346",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion for Severe Left Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2043-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mauro H. Schenone",
"sponsor_slug": "mauro-h-schenone",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03486873",
"publication_url": "https://clinicaltrials.gov/study/NCT03486873",
"title": "A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab",
"has_exemption": false,
"start_date": "2018-08-21",
"completion_date": "2043-08-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06281730",
"publication_url": "https://clinicaltrials.gov/study/NCT06281730",
"title": "Use of New Generation Fetoscopes in Pregnancies Affected by Fetal Diseases Amenable to Fetoscopy Therapy",
"has_exemption": false,
"start_date": "2024-03-23",
"completion_date": "2044-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06358638",
"publication_url": "https://clinicaltrials.gov/study/NCT06358638",
"title": "Sickle Cell Disease Transplant Using a Nonmyeloablative Approach: Adding Daratumumab for Patients With Anti-donor Red Cell AntibodY",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2044-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's National Research Institute",
"sponsor_slug": "childrens-national-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01538056",
"publication_url": "https://clinicaltrials.gov/study/NCT01538056",
"title": "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm: An Investigator Initiated Study",
"has_exemption": false,
"start_date": "2011-03-31",
"completion_date": "2045-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02917460",
"publication_url": "https://clinicaltrials.gov/study/NCT02917460",
"title": "Genomic Biorepository: Protocol for the Collection, Storage, Analysis, and Distribution of Biological Samples, Genomic and Clinical Data",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2050-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rady Pediatric Genomics & Systems Medicine Institute",
"sponsor_slug": "rady-pediatric-genomics-systems-medicine-institute",
"status": "ongoing",
"is_pact": true,
"days_late": null
}
]
}